Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
Public ClinicalTrials.gov record NCT02923115. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b When Added to Standard of Care Anticoagulation Therapy in Subjects With Acute Submassive Pulmonary Embolism
Study identification
- NCT ID
- NCT02923115
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Daiichi Sankyo
- Industry
- Enrollment
- 134 participants
Conditions and interventions
Conditions
Interventions
- DS-1040b Drug
- Placebo Drug
- Enoxaparin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 22, 2016
- Primary completion
- Aug 4, 2019
- Completion
- Aug 4, 2019
- Last update posted
- Apr 18, 2023
2016 – 2019
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pulmonary Associates of Mobile | Mobile | Alabama | 36608 | — |
| Cedars-Sinai Medical Center | Beverly Hills | California | 90211 | — |
| University of California, San Diego (UCSD) Medical Center | San Diego | California | 92103 | — |
| Intercoastal Medical Group | Sarasota | Florida | 34239 | — |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | — |
| University of Kentucky Medical Center | Lexington | Kentucky | 40536 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | — |
| Mercury Street Medical | Butte | Montana | 59701 | — |
| NYU Radiology Associate | New York | New York | 10016 | — |
| Jacobi Medical Center | The Bronx | New York | 10461 | — |
| Duke University Medical Center (DUMC) | Durham | North Carolina | 27710 | — |
| The Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Capital Area Research | Camp Hill | Pennsylvania | 17011 | — |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02923115, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2023 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02923115 live on ClinicalTrials.gov.